Concepedia

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2

Vera Malkovska, Sara Morgan, Andrew Galazka, C Aniszewski, SE Roy, R. J. SHEARER, R.A. Marsden, David Bevan, EC Gordon-Smith, R. Charles Coombes

British Journal of Cancer · 1991 · 69 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity

Steven Gillis, Mary M. Ferm, Winny Ou et al. · The Journal of Immunology · 1978 · 3.3K citations · Full text

, , +13

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

, , +14

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

William H. West, Kurt W. Tauer, John R. Yannelli et al. · New England Journal of Medicine · 1987 · 1.2K citations

, , +16

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

Maury Rosenstein, Stephen E. Ettinghausen, Steven A. Rosenberg · The Journal of Immunology · 1986 · 530 citations · Full text

, , +13